The percentage of TIM-3+ cells was not significantly different between cHL and DLBCL, accounting for a median of 11%, 16% and 7% of cHL, non-GCB DLBCL, and GCB DLBCL tumors, respectively (p = 0.5) (Figure 3D and Figure 4G). Here, HAVCR2 is linked to diffuse large B-cell lymphoma.